This inventor holds 3 USPTO granted patents. Top assignee: Myriad Genetics, Inc.. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2001
Title: The Innovations of Ping Jiang
Introduction
Ping Jiang is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of cancer research through his innovative work on Multiple Tumor Suppressor (MTS) genes. With a total of three patents to his name, Jiang's inventions are paving the way for advancements in cancer therapy and diagnosis.
Latest Patents
One of Jiang's latest patents is related to the Mouse MTS2 gene. This invention focuses on the MTS genes in mice, their expression products, and their homology to human MTS genes, which are implicated in various human cancers. The invention discusses the use of MTS genes in therapy, diagnosis, and prognosis of human cancer. It also addresses mutations in the MTS gene and their role in diagnosing predisposition to several types of cancer, including melanoma, leukemia, and breast cancer. Additionally, the invention explores therapeutic approaches for cancers with MTS gene mutations, including gene therapy and drug screening.
Another significant patent by Jiang is for the Mouse MTSI gene, which shares similar themes with the MTS2 gene patent. This invention also delves into the MTS genes in mice and their relevance to human cancers. It emphasizes the potential for using these genes in cancer therapy and diagnosis, further contributing to the understanding of cancer predisposition and treatment options.
Career Highlights
Ping Jiang is currently employed at Myriad Genetics, Inc., where he continues to work on groundbreaking research in genetics and cancer therapy. His expertise in the field has led to important discoveries that have the potential to improve cancer treatment outcomes.
Collaborations
Jiang collaborates with esteemed colleagues such as Steven Stone and Alexander Kamb. Their combined efforts in research and development are instrumental in advancing the understanding of cancer genetics.
Conclusion
Ping Jiang's innovative work on MTS genes represents a significant advancement in cancer research. His contributions are vital for the development of new therapies and diagnostic tools that could change the landscape of cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile